血液學市場規模、佔有率和成長分析（按產品類型、試劑類型、應用、最終用戶和地區）- 產業預測，2025-2032 年

2023 年全球血液學市場規模價值 91.2 億美元，預計將從 2024 年的 98.7 億美元成長到 2032 年的 185.4 億美元，預測期內（2025-2032 年）的複合年成長率為 8.2%。

全球血液學市場對於貧血、白血病、淋巴瘤和凝血障礙等血液疾病的診斷和監測至關重要。由於老化和生活方式因素導致這些疾病的盛行率不斷上升，以及診斷技術的進步和新治療方法的發展，是成長的主要動力。早期疾病檢測和個人化醫療進一步推動了對先進血液分析儀的需求。然而，市場面臨挑戰，包括先進診斷設備成本高且嚴格的監管合規性。然而，人工智慧、機器學習、就地檢驗和遠端醫療，這些技術可以幫助改善診斷服務的獲取，特別是在資源有限的環境中，從而確保儘管存在障礙，但市場前景仍然強勁。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局
• 專利分析

血液學市場規模（按產品類型和複合年成長率） (2025-2032)

• 市場概況
• 血液分析儀
  • 三部分差異分析裝置
  • 五分類分析儀
  • 照護現場分析儀
• 流式細胞儀
• 凝血分析儀
• 玻片染色設備
• 離心機
• 血紅素測量儀
• 其他

血液學市場規模（按試劑類型和複合年成長率） (2025-2032)

• 市場概況
• 凝血試劑
• 流式細胞技術試劑
• 免疫血液學試劑
• 其他

血液學市場規模（按應用和複合年成長率） (2025-2032)

• 市場概況
• 貧血
• 血癌
• 血友病
• 感染
• 其他

血液學市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 醫院
• 診斷實驗室
• 學術研究所
• 其他

血液學市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Roche（Switzerland）
• Merck & Co.（USA）
• Abbott Laboratories（USA）
• Takeda Pharmaceutical Company（Japan）
• Siemens Healthineers（Germany）
• Alexion Pharmaceuticals（USA）
• Sysmex Corporation（Japan）
• Novartis（Switzerland）
• Amgen（USA）
• Bristol-Myers Squibb（USA）
• Agilent Technologies（USA）
• Bio-Rad Laboratories（USA）
• Danaher Corporation（USA）
• Thermo Fisher Scientific（USA）
• Mindray（China）
• Beckman Coulter（USA）
• Horiba Ltd.（Japan）
• Boule Diagnostics AB（Sweden）
• Hoffmann-La Roche Ltd（Switzerland）

結論和建議

Global Hematology Market size was valued at USD 9.12 billion in 2023 and is poised to grow from USD 9.87 billion in 2024 to USD 18.54 billion by 2032, growing at a CAGR of 8.2% during the forecast period (2025-2032).

The global hematology market is essential for diagnosing and monitoring blood disorders such as anemia, leukemia, lymphoma, and coagulation issues. Significant growth is driven by the rising prevalence of these conditions, influenced by an aging population and lifestyle factors, alongside technological advancements in diagnostics and novel treatment developments. Early disease detection and personalized medicine further boost demand for advanced hematology analyzers. However, the market faces challenges, including the high cost of sophisticated diagnostic equipment and rigorous regulatory compliance. Yet, opportunities remain in technology integration, such as AI and machine learning, point-of-care testing, and telemedicine, facilitating improved access to diagnostic services, especially in resource-limited settings, promising a robust market outlook despite existing barriers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hematology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hematology Market Segmental Analysis

Global Hematology Market is segmented by Product Type, Reagent Type, Application, End User and region. Based on Product Type, the market is segmented into Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Slide Stainers, Centrifuges, Hemoglobinometers and Other. Based on Reagent Type, the market is segmented into Coagulation Reagents, Flow Cytometry Reagents, Immuno-Hematology Reagents and Other. Based on Application, the market is segmented into Anemia, Blood Cancer, Hemophilia, Infection and Other. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories, Academic and Research Institutes and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hematology Market

The growth of the global hematology market is significantly fueled by the rising prevalence of hematological disorders, including conditions like leukemia, lymphoma, and anemia. The World Health Organization reported a notable increase in anemia cases worldwide in 2022, highlighting an urgent demand for effective hematology diagnostics. This heightened incidence of blood-related diseases necessitates the use of advanced hematology analyzers capable of accurately measuring red blood cell counts and hemoglobin levels. Consequently, healthcare providers are seeking reliable diagnostic tools to manage the growing number of patients with these disorders, further propelling the expansion of the hematology sector in the global market.

Restraints in the Global Hematology Market

One of the significant restraints affecting the global hematology market is the high cost associated with advanced hematology equipment. Healthcare facilities, especially those in resource-constrained environments, often struggle to afford the substantial acquisition and maintenance expenses associated with state-of-the-art hematology analyzers and flow cytometers. Additionally, the financial burden of upgrading existing technology and training staff in using these sophisticated tools further complicates matters, creating barriers that hinder widespread adoption. As a result, these financial challenges significantly impact the overall growth and development of the hematology market, limiting accessibility and innovation.

Market Trends of the Global Hematology Market

The Global Hematology market is witnessing a significant trend towards the integration of Artificial Intelligence (AI) in diagnostics, predominantly shaping advancements in 2022 and beyond. AI technologies are revolutionizing blood analysis by enabling more precise identification of subtle abnormalities, which is crucial for accurate disease classification. This integration is enhancing the efficiency of hematology analyzers and flow cytometers while simultaneously processing vast datasets to deliver reliable results. Consequently, the adoption of AI is expected to drive market growth, improve diagnostic outcomes, and streamline workflows in laboratories, positioning AI as a pivotal component in the future of hematology diagnostics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Hematology Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Hematology Analyzers
  • 3-Part Differential Analyzers
  • 5-Part Differential Analyzers
  • Point-of-Care Analyzers
• Flow Cytometers
• Coagulation Analyzers
• Slide Stainers
• Centrifuges
• Hemoglobinometers
• Other

Global Hematology Market Size by Reagent Type & CAGR (2025-2032)

• Market Overview
• Coagulation Reagents
• Flow Cytometry Reagents
• Immuno-Hematology Reagents
• Other

Global Hematology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Anemia
• Blood Cancer
• Hemophilia
• Infection
• Other

Global Hematology Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Academic and Research Institutes
• Other

Global Hematology Market Size & CAGR (2025-2032)

• North America (Product Type, Reagent Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Reagent Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Reagent Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Reagent Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Reagent Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alexion Pharmaceuticals (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horiba Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boule Diagnostics AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations